CN Patent

CN114867517A — 用于与医用流体容器连接的注射端口及其制造方法

Assigned to Fresenius Medical Care Holdings Inc · Expires 2022-08-05 · 4y expired

What this patent protects

本发明涉及一种用于与诸如医用流体容器的容器连接的注射端口。注射端口包括筒体、隔膜和盖，它们通过三次注射成型工艺顺次形成。本发明还涉及一种组件，该组件包括连接到容器的注射端口。此外，本发明涉及一种利用三次注射成型工艺制造注射端口的方法。

USPTO Abstract

本发明涉及一种用于与诸如医用流体容器的容器连接的注射端口。注射端口包括筒体、隔膜和盖，它们通过三次注射成型工艺顺次形成。本发明还涉及一种组件，该组件包括连接到容器的注射端口。此外，本发明涉及一种利用三次注射成型工艺制造注射端口的方法。

Drugs covered by this patent

ropivacaine-hydrochloride (ROPIVACAINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN114867517A
Jurisdiction: CN
Classification: —
Expires: 2022-08-05
Drug substance claim: No
Drug product claim: No
Assignee: Fresenius Medical Care Holdings Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.